Why Beacon?
Discover how Beacon Microbiome enables data-driven insight that will accelerate your Microbiome development decisions
- Validate Microbiome asset potential with insights on competitor programs, clinical outcomes, and market activity
- Explore Microbiome drug design strategies from therapeutic class and approved disease indications to microbiome therapy engineering and species
- Benchmark your research with validated preclinical data, including publication summaries, and links to conference abstracts and posters
- Optimize clinical trial design by analyzing trial endpoints, outcomes, and regulatory precedents, to accelerate progression into the clinic
- Find the right partners in a competitive market, by tracking new companies, collaborations, and licensing deals, as they emerge
Join 24/25 top Pharma companies who use Beacon to accelerate and improve their drug development decisions.
Request Beacon Microbiome Demonstration
Please submit the form below to request your personalized demonstration of the Beacon Microbiome platform. A member of our specialized team will be in touch shortly to schedule a time that suits you.
How is Beacon Microbiome Different?
- A Unique Microbiome Dataset: Comprehensive & accurate, preclinical and clinical, Microbiome drug, trial and commercial data to inform your Microbiome development decisions
- In Depth Preclinical Data: Including preclinical publication summaries, and links to conference abstracts and posters
- Proprietary Ontologies: Market leading standardized ontologies, enabling you to easily segment the Microbiome drug development landscape, to quickly find the data that matters to you
- Human Intelligence: Beacon Microbiome data is manually curated by sector specialist analysts, to ensure data accuracy and integrity
Search